ORPEA in the news

Emeis completed the sale of its Latin American activities for 111 million euros, refocusing on European markets and improving its financial structure.

Orpea SA's stock, traded as OPA1.SG, shows a price of 9.99 with no change.

Emeis (ORPEA) held its Q1 2026 revenue conference call with Jean-Marc Boursier and Samuel Henry Diesbach.

The Orpea scandal, detailed in a 2022 book, exposed systemic failures in elderly care, leading to increased awareness but a continued lack of resources for the sector.

A book exposing scandals at Orpea's nursing homes led to increased awareness of systemic failures and underfunding in elderly care.

The Orpea scandal, exposed in a 2022 book, revealed widespread elder mistreatment, toxic management, and financial impropriety, sparking a national reckoning on systemic failures and underfunding in elderly care.

Emeis's CEO highlights insufficient resources, governmental instability, and a lack of investment hindering the elderly care sector's ability to meet growing demands, stressing the need for long-term planning and staff development.

The Council of Europe highlights critical understaffing, insufficient funding, and inadequate infrastructure in French nursing homes, prompting the French government to acknowledge challenges and detail ongoing investment and recruitment efforts.

The Council of Europe has raised concerns about the inadequate resources, poor conditions, and understaffing in French nursing homes, four years after the Orpea scandal.

Two former Orpea directors will face trial for insider trading and money laundering related to stock sales before a scandal involving resident mistreatment and financial misconduct became public.

Two former Orpea directors will be tried in Paris for insider trading and money laundering related to stock sales prior to a scandalous book's release exposing company misconduct.

Two former directors of Orpea will be tried in Paris for insider trading and money laundering related to a stock resale before a damning book about the company's practices was published.

Two former Orpea directors face trial for insider trading, prompting shareholders to consider legal recourse for direct personal damages.

Former Orpea CEO and Deputy CEO are facing insider trading charges related to the "Orpea affair."

Two former Orpea directors face trial for insider trading and money laundering related to stock sales before a scandal exposé.

Yann Finck's algorithms identify Orpea as the European leader in dependency care, with a more pessimistic view on Elior Group.

Jean-François Arnaud advises purchasing Orpea stock, a European leader in nursing homes and rehabilitation clinics with over 70,000 beds.

Jean-François Arnaud advises purchasing shares in Orpea, a leading European operator of nursing homes and rehabilitation clinics.

emeis stock is rising due to strong first-half results, positive analyst review from AlphaValue, and an increased EBITDAR growth target for 2026.

emeis (formerly Orpea) has raised its 2026 financial targets following a strong performance driven by increased occupancy rates and improved profitability.